NGS Group (NGS) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jun, 2025Executive summary
Net sales for Q1 2025 were 76 MSEK, a 20% decrease year-over-year, mainly due to a weaker healthcare staffing market following political decisions reducing demand for external staff.
EBITA improved significantly to -0.1 MSEK from -6.6 MSEK in Q1 2024, reflecting successful cost control and sales efforts.
The school staffing business was divested, generating a 2.5 MSEK gain, mostly in shares of Tellusgruppen AB.
The long-term Nordea loan was fully amortized (10.4 MSEK), eliminating covenant requirements.
Financial highlights
Net income for Q1 2025 was -0.8 MSEK, compared to -6.1 MSEK in Q1 2024.
Earnings per share improved to -0.03 SEK from -0.68 SEK year-over-year.
Cash flow from operating activities was -10.2 MSEK, down from -6.4 MSEK in Q1 2024.
Liquidity at period end was 4.5 MSEK, up from 1.3 MSEK a year earlier.
Soliditet (equity ratio) increased to 61.9% from 51.2% year-over-year.
Outlook and guidance
The company aims for at least 10% organic and acquisition-driven sales growth over time, with an EBITA margin target of 4%.
Dividend policy is to distribute 40-50% of net profit, subject to financial position.
Latest events from NGS Group
- EBITA turned positive in 2025, but goodwill write-down led to a net loss and no dividend.NGS
Q4 202526 Feb 2026 - Q3 sales dropped 18% but EBITA improved; new CEO and Human Capital brand launched.NGS
Q3 20256 Nov 2025 - EBITA returned to positive in Q2 2025 amid revenue decline and challenging market conditions.NGS
Q2 20257 Aug 2025 - Q3 sales dropped 27% but profitability and equity ratio improved amid market challenges.NGS
Q3 202413 Jun 2025 - Sharp revenue decline and heavy losses in H1 2024; cost cuts and new deals target recovery.NGS
Q2 202413 Jun 2025 - Q4 EBITA returned to profit despite lower sales, driven by cost control and segment focus.NGS
Q4 20245 Jun 2025